The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data
Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223
Glutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402
Long-Term Potentiation and Memory
LYNCH, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 1,991
Bredt, D. S., Glatt, C. E., Hwang, P. M., Fotuhi, M., Dawson, T. M., & Snyder, S. H. (1991) · Neuron · doi:10.1016/0896-6273(91)90374-9 · Cited by 1,359
A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation
Schuman, E. M., & Madison, D. V. (1991) · Science · doi:10.1126/science.1720572 · Cited by 1,141
O'Dell, T. J., Hawkins, R. D., Kandel, E. R., & Arancio, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11285 · Cited by 1,035
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
Soderling, S. H., & Beavo, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00073-3 · Cited by 736
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
Buckley, N. J., Bonner, T. I., Buckley, C. M., & Brann, M. R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11261-3 · Cited by 635
Possible involvement of nitric oxide in long-term potentiation
Böhme, G. A., Bon, C., Stutzmann, J.-M., Doble, A., & Blanchard, J.-C. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90505-k · Cited by 632
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W., & Sibley, D. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46830-x · Cited by 507
Cited by
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Concepts of neural nitric oxide‐mediated transmission
Garthwaite, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06285.x · Cited by 807
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Lakics, V., Karran, E. H., & Boess, F. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.004 · Cited by 463
Self-citationROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Phosphodiesterases in the CNS: targets for drug development
Menniti, F. S., Faraci, W. S., & Schmidt, C. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2058 · Cited by 391
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Fischmeister, R., Castro, L. R. V., Abi-Gerges, A., Rochais, F., Jurevičius, J., Leroy, J., & Vandecasteele, G. (2006) · Circulation Research · doi:10.1161/01.res.0000246118.98832.04 · Cited by 367
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1053 · Cited by 325
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species
Stephenson, D. T., Coskran, T. M., Wilhelms, M. B., Adamowicz, W. O., O'Donnell, M. M., Muravnick, K. B., Menniti, F. S., Kleiman, R. J., & Morton, D. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953471 · Cited by 289
Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes
Castro, L. R. V., Verde, I., Cooper, D. M. F., & Fischmeister, R. (2006) · Circulation · doi:10.1161/circulationaha.105.599241 · Cited by 274
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 266
Self-citationPhosphodiesterases as Therapeutic Targets for Alzheimer's Disease
García-Osta, A., Cuadrado-Tejedor, M., García-Barroso, C., Oyarzábal, J., & Franco, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000907 · Cited by 259
cGMP Signalling in the Mammalian Brain: Role in Synaptic Plasticity and Behaviour
Kleppisch, T., & Feil, R. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_24 · Cited by 161
Metadata
- Authors
- Boess, F. G., Hendrix, M., van der Staay, F.-J., Erb, C., Schreiber, R., van Staveren, W., de Vente, J., Prickaerts, J., Blokland, A., & Koenig, G.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 47
- Issue
- 7
- Pages
- 1081-1092
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2143070083
- Cited by
- 330
- References
- 64
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.